Telik, Inc. (TELK)
A biopharmaceutical company working to discover, develop and commercialize innovative small molecule drugs to treat diseases.
Recs
YeahBuddy79
(82.42)
Submitted: 5/5/2008 10:56:39 PM :
Start Price:
$2.16
TELK Score:
+44.99
Embarrassing at best. All the posts have already noted the deaths and that it kills people. As if that is not enough for you, this stock has a bad track record and it is falling faster then Cheney's approval rating. Not trying to get political (but it is true). Alright if you don’t know by now I really feel sorry for you. NEVER invest in the “cure for cancer” they will not find a cure they will find away to make you live with it. Don’t like that tuff break. The truth hurts. It is not like I want that don’t kill the informer. To be honest with you no company should be able to survive this. If it does I buy the CEOs a trophy for best killer that got away with it.
Recs
PueoFool
(< 20)
Submitted: 2/27/2008 12:33:39 PM :
Start Price:
$2.70
TELK Score:
-53.41
This is my vegas-style gamble for the week.
Recs
invstm1000
(37.14)
Submitted: 10/22/2007 7:48:52 PM :
Start Price:
$3.84
TELK Score:
+55.48
lousy management, questionable drug, all in all these is easy money selling short.
Recs
GunnarVagotis
(95.09)
Submitted: 9/26/2007 7:52:16 PM :
Start Price:
$3.12
TELK Score:
+50.07
Holy smokes, this stock is up 3% and their drug kills cancer patients faster than if they didn't take the drug. I've got an idea. If you are thinking about buying this stock, just send your money to me. I will send you half of it back and we both win.
Recs
n00bs
(< 20)
Submitted: 6/21/2007 9:51:16 PM :
Start Price:
$3.40
TELK Score:
-53.18
grab some points
Recs
majakblue
(< 20)
Submitted: 6/6/2007 3:53:47 PM :
Start Price:
$3.52
TELK Score:
+53.92
Gotta love those pharma wannabes. Phase III trials a bust, no profitability, spend the money on lottery tickets--less risk. Come on TELIK, improve my score ;->.
Recs
POWFred
(49.16)
Submitted: 5/3/2007 5:27:44 PM :
Start Price:
$6.00
TELK Score:
-63.84
small pharma company with a few things in the pipeline. success and take over, or slow growth over longer time say 5 years.
Recs
Recs
Moska
(< 20)
Submitted: 2/18/2007 8:32:47 PM :
Start Price:
$5.66
TELK Score:
-66.12
Despite its failure in the drug tests, it has been way oversold and still has potential to bring in other drugs.
Recs
Recs
tribucks
(< 20)
Submitted: 1/31/2007 2:59:32 PM :
Start Price:
$6.55
TELK Score:
-68.95
NEXT 6 MOS. WILL HIT OVER 8
Recs
Comatosis2007
(< 20)
Submitted: 12/28/2006 9:23:06 AM :
Start Price:
$4.40
TELK Score:
+63.94
Nothing of value anymore.
Recs
vic50us
(< 20)
Submitted: 12/21/2006 10:10:35 PM :
Start Price:
$15.79
TELK Score:
-77.17
huge investment must have results
Recs
ponyman1331
(56.20)
Submitted: 12/16/2006 11:34:06 AM :
Start Price:
$16.90
TELK Score:
-76.97
will show positive results in phase 3 test
Recs
mmachiz
(60.77)
Submitted: 12/14/2006 11:49:48 PM :
Start Price:
$16.44
TELK Score:
-76.67
phase three results about to be announced will be favorable, delays in announcing results to date can only be explained by unusual survival benefits
Recs
PopsDaniecki
(96.99)
Submitted: 10/19/2006 6:54:19 AM :
Start Price:
$19.74
TELK Score:
-81.35
BIOTECH SCARES ME! But when it looks like there's a good chance to make a nickel, I'll bite. Research this a great deal and you may agree here.
Recs
target213
(< 20)
Submitted: 10/10/2006 3:43:10 PM :
Start Price:
$17.62
TELK Score:
-81.54
I think there will be news regarding their drug line
Recs
bighorse4
(< 20)
Submitted: 10/9/2006 12:53:19 PM :
Start Price:
$17.67
TELK Score:
-81.73
bio meds are way over sold. This bling bling is an FDA approval away from a real gem.
Recs
not2lazy
(< 20)
Submitted: 9/20/2006 4:47:54 AM :
Start Price:
$17.71
TELK Score:
-83.54
Critical data due anytime
Recs
bioman100
(< 20)
Submitted: 8/24/2006 10:07:41 PM :
Start Price:
$16.72
TELK Score:
-85.48
breakthrough cancer drugs in development
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 20